Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/1998
10/01/1998WO1998029555A3 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/01/1998CA2596303A1 Vectors and viral vectors and packaging cell lines for propogating same
10/01/1998CA2284685A1 Noey2 gene compositions and methods of use
10/01/1998CA2284611A1 Replication-competent herpes simplex viruses
09/1998
09/30/1998EP0866721A1 Targeted adenovirus vectors
09/30/1998CN1194584A Method for industrially producing a Japanese encephalitis vaccine, and resulting vaccine
09/29/1998US5814510 Attenuated canine parvovirus vaccine
09/29/1998US5814315 Methods for the suppression of neu mediated phenotype in tumors
09/29/1998CA1340062C Method of inactivating reproductive filterable pathogens
09/24/1998WO1998041619A1 Attenuated polioviruses
09/24/1998WO1998041618A1 Method for the purification of virus
09/24/1998WO1998041240A1 Methods and compositions for use in gene therapy for treatment of hemophilia
09/24/1998CA2283639A1 Methods and compositions for use in gene therapy for treatment of hemophilia
09/24/1998CA2283638A1 Attenuated polioviruses
09/23/1998EP0866136A1 Recombinant library screening methods
09/23/1998EP0865493A2 Viral vectors
09/22/1998US5811407 Using alphaviruses as vectors containing immunogenic or therapeutic proteins;
09/22/1998US5811274 Depositing viral particles or carriers on cell growth support, contacting target cells; efficiency;
09/22/1998US5811104 Efficacious vaccine against feline infectious peritonitis virus; manipulation to generate an immune response.
09/22/1998US5811093 Bacteriophage genotypically modified to delay inactivations by the host defense system
09/17/1998WO1998040509A1 Chimeric adenoviral coat protein and methods of using same
09/17/1998WO1998040507A1 Expression of a modified foamy virus envelope protein
09/17/1998DE19709186A1 Filtrationsverfahren zur Trennung von Viren Filtration methods for separating viruses
09/17/1998CA2283628A1 Chimeric adenoviral coat protein and methods of using same
09/16/1998EP0864652A1 Expression of a foamy virus envelope protein
09/16/1998EP0864646A2 Process for the inactivation of enveloped viruses
09/16/1998EP0864645A1 (-)-strand rna virus vector having autonomously replicating activity
09/16/1998EP0863988A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome
09/16/1998EP0863987A2 Vectors and methods for gene transfer to cells
09/16/1998EP0863982A1 Synthetic hpv11 virus-like particles
09/16/1998EP0493575B1 Rotavirus reassortant vaccine
09/13/1998CA2229515A1 Expression of a foamy virus envelope protein
09/13/1998CA2199989A1 Expression of a foamy virus envelope protein
09/11/1998WO1998039482A1 Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
09/11/1998WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
09/11/1998WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
09/11/1998WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
09/11/1998WO1998039463A2 Lentivirus based vector and vector system
09/11/1998WO1998039428A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
09/11/1998WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998WO1998039420A1 Filtration method for separating viruses
09/11/1998WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/11/1998WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998WO1998029535A3 Nanoscale particles synthesized within an assembled virion
09/11/1998CA2283241A1 Filtration method for separating viruses
09/11/1998CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/10/1998DE19709512A1 Recombinant influenza virus
09/09/1998EP0863202A1 Recombinant sendai virus
09/09/1998EP0862643A1 Accessory functions for use in recombinant aav virion production
09/09/1998EP0862633A1 Virus protein antigens of the jc virus
09/09/1998CN1192783A Marek's disease virus genes and their use in vaccines for protection against marek's disease
09/08/1998US5804439 Plasmid encoding hybrid RNA virus
09/08/1998US5804431 Method, compositions and apparatus for cell transfection
09/08/1998US5804430 Bovine ovary cell line (FROV) for virus replication
09/08/1998US5804413 Herpes simplex virus strains for gene transfer
09/08/1998US5804197 Recombinant canine herpesviruses
09/03/1998WO1998037911A1 Chimeric flavivirus vaccines
09/03/1998WO1998037905A1 Arrestable therapeutic viral agent
09/03/1998WO1998012339A3 Viral vectors and their uses
09/03/1998DE19709148C1 Verfahren zur Herstellung eines Impfstoffes gegen infektiöse Erreger A process for the preparation of a vaccine against infectious agents
09/03/1998CA2280690A1 Arrestable therapeutic viral agent
09/02/1998EP0861901A2 Recombinant insect viruses comprising insect transcription factors
09/02/1998EP0861665A1 Infectious bursitis vaccine
09/02/1998EP0698091B1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
09/01/1998US5801042 Dna and nucleic acids for herpesvirus glycoprotein h, plasmids and genomes
09/01/1998US5801029 Cytopathic viruses for therapy and prophylaxis of neoplasia
09/01/1998US5801005 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
09/01/1998US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains
09/01/1998US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
08/1998
08/27/1998WO1998037216A1 Recombinant chimeric viruses and uses thereof
08/27/1998WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow
08/27/1998WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/26/1998EP0860700A2 Use of HSV-1 UL-15 and VP5 in identifying anti-viral agents
08/26/1998EP0859856A2 Stable packaging cell line producing pseudotyped retroviruses
08/26/1998EP0859831A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences
08/26/1998EP0859639A1 Methods for treating cancers and restenosis with p21
08/26/1998EP0557427B1 Human rotaviruses, vaccines and methods
08/25/1998US5798265 Encoding rna complementary to message rna; antisense agents
08/25/1998US5798250 Facilitating hepatitus virus infection in cell culture using a membrane stressor
08/25/1998US5798238 Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
08/25/1998US5798205 Isolated protein or polypeptide; for detecting antibodies against htlv
08/21/1998CA2223032A1 Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795768 Genetic engineering
08/18/1998US5795754 Human papilloma virus
08/18/1998US5795743 A (glyco)protein
08/18/1998US5795579 Herpes simplex virus VP16 vaccines
08/13/1998WO1998035062A1 Multistep, atp-dependent cell-free system for the assembly of human immunodeficiency virus capsids
08/13/1998WO1998035024A1 New spumavirus isolated from humans
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998013501A3 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
08/13/1998CA2280275A1 New spumavirus isolated from humans
08/13/1998CA2280195A1 Synthetic hiv gag genes
08/12/1998EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption
08/12/1998EP0857210A1 Therapeutic antiangiogenic compositions and methods
08/12/1998EP0857207A1 Microporous pathogen-killing composition
08/12/1998EP0857204A1 Method of adsorbing viruses from fluid compositions
08/12/1998EP0857069A1 Methods of preserving microorganisms
08/12/1998EP0701450B1 Recombinant viruses and their use in gene therapy
08/12/1998CN1190402A Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 267